Omeprazol Ratiopharm (Omeprazole)

Omeprazole irreversibly inhibits the H+/K+‑ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it lowers both basal and stimulated gastric acidity, allowing mucosal healing and symptom relief.

The specific dose and treatment duration are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals tailor the regimen to each individual case.

Safety in pregnancy and lactation should be evaluated by a qualified healthcare provider. Omeprazole is classified as Category B in many regions, indicating that animal studies have not shown risk, but adequate human data are limited. The prescriber will weigh potential benefits against any possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Omeprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Store the tablets below 25 °C in a dry place, preferably in the original container to protect from moisture and light. Do not expose the product to excessive heat or humidity, as this may affect its stability.

Omeprazol Ratiopharm is supplied as oral tablets that are usually taken before a meal, often in the morning. The tablet should be swallowed whole with water and not crushed or chewed, unless the prescriber provides specific instructions.

Serious but rare risks include Clostridioides difficile‑associated diarrhoea, acute interstitial nephritis, severe hypomagnesemia, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should report any unexplained severe symptoms to their healthcare provider promptly.

Patients with known hypersensitivity to omeprazole or any component of the formulation should not use the product. Caution is also advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of certain infections or bone disorders, unless directed otherwise by a clinician.